Small Pharma, Inc. is a neuropharmaceutical company specialized in IP-led development of novel treatments for mental health conditions, with a focus on depression. It initiated a clinical program into DMT-assisted therapy in February 2021. This program includes a Phase I/IIa trial on the Company's lead candidate alongside development of a robust pipeline of proprietary preclinical assets. The company was founded on January 23, 2018 and is headquartered in Vancouver, Canada.
Industry:
Drugstore Chains